International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.14211007
Original Research Article
Sinonasal Inverted Papilloma – Presentation and Management
Published
Nov. 24, 2024
Abstract

Background: Inverted papilloma is a true epithelial neoplasm of sinonasal cavity. It has a incidence rate of 0.6 cases/100000 people/year. The characteristic features of inverted papilloma are the presence of associated nasal polyps, its tendency to recur, destructive potential and malignant transformation. Objectives: To review the presentation of sinonasal inverted papilloma and its management and review of literature.Method: A retrospective study consisting of 4 diagnosed cases of inverted papilloma of sinonasal cavity which were treated at our tertiary care centre between the period March 2022 to June 2023. Results: 1 out of 4 cases had bits of malignant tissue (squamous cell carcinoma) in the histopathological examination of the completely excised specimen and was referred to higher centre for radiotherapy. Rest 3 cases were completely cleared off the pathology and on regular follow up and no recurrence reported till date.Conclusion: Radical surgery is required for histopathologically proven cases of Inverted papilloma preoperatively, since there is high chance of recurrence if inadequately removed. All histopathologically proven cases of inverted papilloma have to undergo complete surgical clearance of the pathology. The entire specimen has to be sent to histopathological examination again to cross confirm and rule out malignancy. Also the patient should be asked to be on regular follow up to rule out recurrence.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
2799 Views
454 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved